Skip to main content
Gregory Riedlinger, MD, Pathology, New Brunswick, NJ

GregoryMRiedlingerMD

Pathology New Brunswick, NJ

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Physician

Are you Dr. Riedlinger?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 17 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    Rutgers Cancer Institute of New Jersey
    195 Little Albany Parkway Room 3553
    New Brunswick, NJ 08903
    Phone+1 732-235-8978

Summary

  • Dr. Gregory Riedlinger, MD is a board certified pathologist in New Brunswick, New Jersey. He is currently licensed to practice medicine in New Jersey, Massachusetts, and Maryland. He is affiliated with Robert Wood Johnson University Hospital.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterResidency, Pathology-Anatomic and Clinical, 2010 - 2013
  • Wake Forest School of Medicine of Wake Forest Baptist Medical Center
    Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2009

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2015 - 2025
  • PA State Medical License
    PA State Medical License 2013 - 2016
  • MA State Medical License
    MA State Medical License 2013 - 2014
  • MD State Medical License
    MD State Medical License 2013 - 2013
  • American Board of Pathology Pathology - Anatomic
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Press Mentions

  • Solid Tumor Genomic Sequencing Can Reveal Coexistent Hematologic Malignancy
    Solid Tumor Genomic Sequencing Can Reveal Coexistent Hematologic MalignancyJanuary 2nd, 2019
  • CHIPing Away at Cancer Tumors Through Genomic Analysis
    CHIPing Away at Cancer Tumors Through Genomic AnalysisApril 23rd, 2018